Latest News

Friday, January 30, 2015 | Product Releases

Mile High Ophthalmics Joins University of Colorado to Launch Device Easing Cataract Surgery

A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC, accordi…

Read the full story

Friday, January 30, 2015 | Cataract Surgery, FDA Approval/Clearance, Abbott Medical Optics

FDA Approves Two New Tecnis Multifocal IOLs

Abbott Medical Optics (AMO) announced that two new Tecnis Multifocal IOLs have received FDA approval. The Tecnis Multifocal +2.75 D and +3.25 D IOLs are now available, along with the previously-approv…

Read the full story

Friday, January 30, 2015 | Miscellaneous

New PSA Campaign Promotes Better Eye Health

Targeting the growing rates of glaucoma and macular degeneration, the BrightFocus Foundation launched a new Public Service Announcement (PSA) campaign, “Make a Plan Today: Get Your Eyes Checked,…

Read the full story

Friday, January 30, 2015 | Medical Studies, Retina

Age-Related Macular Degeneration May Be Triggered by Tiny Mineral Deposits

New research from scientists at the University of Maryland School of Medicine (UM SOM) has found that tiny lumps of calcium phosphate may be an important triggering factor for AMD, a degenerative eye …

Read the full story

Thursday, January 29, 2015 | Health Care

CMS Intends to Shorten Meaningful Use Reporting Period

The Centers for Medicare and Medicaid Services on Thursday announced that it intends to update rules for the Electronic Health Record (EHR) Incentive Programs in 2015, with the goal of reducing t…

Read the full story

Thursday, January 29, 2015 | Earnings & Financials

OPKO and Pfizer Receive Regulatory Clearance for Global Agreement

OPKO Health and Pfizer announced the closing of their worldwide agreement for the development and commercialization of hGH-CTP, a long-acting human growth hormone, according to a company news re…

Read the full story

Thursday, January 29, 2015 | Clinical Trials, Glaucoma

Envisia Therapeutics Initiates Phase 2a Clinical Trial for ENV515 in Patients with Glaucoma

Envisia Therapeutics announced that it has initiated a phase 2a clinical trial to investigate the safety and tolerability of its lead product, ENV515, in patients with glaucoma, according to a company…

Read the full story

Thursday, January 29, 2015 | Earnings & Financials, Presbia

Presbia Announces Pricing of Initial Public Offering

Presbia PLC, an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens, announced the pricing of its initial public offering of 4,166,667 ordinary share…

Read the full story

Thursday, January 29, 2015 | Medical Studies

Slight Posterior Corneal Protrusion After LASIK and PRK

Femtosecond laser-assisted LASIK and photorefractive keratectomy (PRK) are both associated with mild but statistically significant forward protrusion of the posterior cornea. According to results from…

Read the full story

Thursday, January 29, 2015 | Medical Studies

Surgery Cannot Completely Undo the Brain Rewiring Caused by Long-Term Blindness So How Does the Brain Adapt?

Recent scientific advances have meant that eyesight can be partially restored to those who previously would have been blind for life. However, scientists at the University of Montreal and the Universi…

Read the full story

Wednesday, January 28, 2015 | Miscellaneous

Ophthalmic Pioneer George Waring III Passes Away at Age 73

Ophthalmic pioneer George Waring III, MD, FACS, FRCOphth, passed away this week at the age of 73. Dr. Waring’s career in ophthalmology has spanned more than 30 years. Born in Buffalo, New Yor…

Read the full story

Wednesday, January 28, 2015 | Practice Development

Nvision Eye Centers Announce Change in Location and Leadership

After 15 years at its Newport Beach, California location, Nvision Eye Centers, one of the largest providers of LASIK and cataract surgery in the US, has moved its headquarters to the city of Aliso Vie…

Read the full story

Wednesday, January 28, 2015 | Management/Leadership, TearLab Corp.

TearLab Appoints Raymond Kong as Vice President of Sales

TearLab announced the appointment of Raymond Kong to its senior management team as vice president of sales, according to a company news release. Mr. Kong succeeds Duane Morrison, who will shift his fo…

Read the full story

Wednesday, January 28, 2015 | Blindness

Researchers Advance the Science Behind Treating Patients with Corneal Blindness

Researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute have devised a novel way to generate transplantable corneal stem cells that may eventually benefit patients suffering…

Read the full story

Tuesday, January 27, 2015 | Miscellaneous

Living Well with Low Vision Partners with Enablemart to Support Growing Community of People with Low Vision

Visitors to Living Well with Low Vision,, will now be able to purchase low vision aids and products through, a premier provider of products for people wit…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $27.96  -2.48% 
 Akorn, Inc. $42.58  -1.00% 
 Alimera Sciences, Inc. $5.43  1.69% 
 Allergan, Inc. $219.26  -1.39% 
 Avalanche $39.68  -3.24% 
 Bayer $143.48  -0.33% 
 Can-Fite Biopharma $3.22  -4.17% 
 Carl Zeiss Meditec $23.36  -0.32% 
 Cooper Companies, Inc. $157.65  -1.52% 
 Escalon Medical Corp. $1.43  -4.67% 
 Essilor International $110.50  0.00% 
 Imprimis Pharmaceuticals, Inc. $7.37  3.07% 
 InSite Vision, Inc. $0.19  -9.57% 
 IRIDEX Corporation $9.05  0.22% 
 Johnson & Johnson $100.14  -1.32% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $59.27  1.66% 
 Merck & Company, Inc. $60.28  -1.90% 
 NicOx $1.94  0.52% 
 NovaBay Pharmaceuticals, Inc. $0.64  2.42% 
 Novartis AG Common Stock $97.40  0.30% 
 Ocular Therapeutix $30.48  5.72% 
 Ophthotech Corporation $56.25  2.19% 
 Quantel $3.01  -4.14% 
 Regeneron $416.66  2.12% 
 Roche $33.76  -2.06% 
 STAAR Surgical Company $6.00  5.08% 
 TearLab Corporation $1.69  -0.59% 
 Thrombogenics $8.46  0.00% 
 Topcon Corporation $19.85  0.66% 
 Valeant Pharmaceuticals $159.97  -0.39% 
 Xoma $3.56  -4.30%